Predicting the outcome of prostate biopsy: comparison of a novel logistic regression‐based model, the prostate cancer risk calculator, and prostate‐specific antigen …

DJ Hernandez, M Han, EB Humphreys… - BJU …, 2009 - Wiley Online Library
OBJECTIVES To develop a logistic regression‐based model to predict prostate cancer
biopsy at, and compare its performance to the risk calculator developed by the Prostate …

[HTML][HTML] Predicting the outcome of prostate biopsy: comparison of a novel logistic regression-based model, the prostate cancer risk calculator, and prostate-specific …

DJ Hernandez, M Han, EB Humphreys… - Bju …, 2009 - ncbi.nlm.nih.gov
OBJECTIVES To develop a logistic regression-based model to predict prostate cancer
biopsy at, and compare its performance to the risk calculator developed by the Prostate …

Predicting the outcome of prostate biopsy: comparison of a novel logistic regression-based model, the prostate cancer risk calculator, and prostate-specific antigen …

DJ Hernandez, M Han, EB Humphreys… - BJU …, 2008 - europepmc.org
Objectives To develop a logistic regression-based model to predict prostate cancer biopsy
at, and compare its performance to the risk calculator developed by the Prostate Cancer …

Predicting the outcome of prostate biopsy: comparison of a novel logistic regression-based model, the prostate cancer risk calculator, and prostate-specific antigen …

DJ Hernandez, M Han, EB Humphreys… - BJU …, 2009 - search.ebscohost.com
OBJECTIVES To develop a logistic regression-based model to predict prostate cancer
biopsy at, and compare its performance to the risk calculator developed by the Prostate …

[PDF][PDF] Predicting the outcome of prostate biopsy: comparison of a novel logistic regression-based model, the prostate cancer risk calculator, and prostate-specific …

DJ Hernandez, M Han, EB Humphreys, LA Mangold… - Prostate, 2008 - academia.edu
RESULTS Prostate cancer was detected in 394 (35.6%) men, and 155 (14.0%) had
Gleason≥ 7 disease. For cancer prediction, the area under the ROC curve (AUC) for the risk …

Predicting the outcome of prostate biopsy: Comparison of a novel logistic regression-based model, the prostate cancer risk calculator, and prostate-specific antigen …

DJ Hernandez, M Han, EB Humphreys… - BJU …, 2009 - nyuscholars.nyu.edu
OBJECTIVES: To develop a logistic regression-based model to predict prostate cancer
biopsy at, and compare its performance to the risk calculator developed by the Prostate …

[引用][C] Predicting the outcome of prostate biopsy: comparison of a novel logistic regression-based model, the prostate cancer risk calculator, and prostate-specific …

DJ HERNANDEZ, M HAN… - BJU international …, 2009 - pascal-francis.inist.fr
Predicting the outcome of prostate biopsy : comparison of a novel logistic regression-based
model, the prostate cancer risk calculator, and prostate-specific antigen level alone CNRS …

Predicting the outcome of prostate biopsy: comparison of a novel logistic regression-based model, the prostate cancer risk calculator, and prostate-specific antigen …

DJ Hernandez, M Han, EB Humphreys… - BJU …, 2009 - pubmed.ncbi.nlm.nih.gov
Objectives To develop a logistic regression-based model to predict prostate cancer biopsy
at, and compare its performance to the risk calculator developed by the Prostate Cancer …

[PDF][PDF] Predicting the outcome of prostate biopsy: comparison of a novel logistic regression-based model, the prostate cancer risk calculator, and prostate-specific …

DJ Hernandez, M Han, EB Humphreys, LA Mangold… - Prostate, 2008 - Citeseer
RESULTS Prostate cancer was detected in 394 (35.6%) men, and 155 (14.0%) had
Gleason≥ 7 disease. For cancer prediction, the area under the ROC curve (AUC) for the risk …

Predicting the outcome of prostate biopsy: Comparison of a novel logistic regression-based model, the prostate cancer risk calculator, and prostate-specific antigen …

DJ Hernandez, M Han, EB Humphreys… - BJU …, 2009 - pure.johnshopkins.edu
OBJECTIVES: To develop a logistic regression-based model to predict prostate cancer
biopsy at, and compare its performance to the risk calculator developed by the Prostate …